Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

News Daily News

SWIFT PRIME Analysis Underscores Importance of ‘Time Is Brain’ Concept in Acute Stroke

Todd Neale

April 20, 2016

News Conference News ISC 2016

To Anticoagulate or Not? Debating Secondary Stroke Prevention in an A-fib Patient With Microbleeds

Michael O'Riordan

February 23, 2016

News Daily News

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Yael L. Maxwell

February 22, 2016

News Conference News ISC 2016

Neurointervention Groups Set Standards for Performing Endovascular Stroke Therapy

Todd Neale

February 16, 2016

News Industry News

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

October 15, 2015

News Daily News

Pooled Data From IMS III, MR CLEAN Further Support Endovascular Therapy for Severe Stroke

L.A. McKeown

February 19, 2015

News Daily News

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

Todd Neale

February 17, 2015

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

Advertisement

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

SWIFT PRIME Analysis Underscores Importance of ‘Time Is Brain’ Concept in Acute Stroke

To Anticoagulate or Not? Debating Secondary Stroke Prevention in an A-fib Patient With Microbleeds

PFO Closure Faces Renewed Scrutiny in Patient-Level Meta-Analysis

Neurointervention Groups Set Standards for Performing Endovascular Stroke Therapy

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

Pooled Data From IMS III, MR CLEAN Further Support Endovascular Therapy for Severe Stroke

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content